Hologic, Inc. (BVMF:H1OL34)

Hologic Statistics

Total Valuation

Hologic has a market cap or net worth of BRL 87.88 billion. The enterprise value is 89.50 billion.

Market Cap	87.88B
Enterprise Value	89.50B

Important Dates

The last earnings date was Monday, November 3, 2025.

Earnings Date	Nov 3, 2025
Ex-Dividend Date	n/a

Share Statistics

Current Share Class	n/a
Shares Outstanding	n/a
Shares Change (YoY)	-4.20%
Shares Change (QoQ)	+0.12%
Owned by Insiders (%)	0.97%
Owned by Institutions (%)	99.31%
Float	220.23M

Valuation Ratios

The trailing PE ratio is 29.08 and the forward PE ratio is 16.30.

PE Ratio	29.08
Forward PE	16.30
PS Ratio	4.01
PB Ratio	3.26
P/TBV Ratio	20.11
P/FCF Ratio	17.88
P/OCF Ratio	15.56
PEG Ratio	n/a

Enterprise Valuation

The stock's EV/EBITDA ratio is 13.08, with an EV/FCF ratio of 18.21.

EV / Earnings	29.61
EV / Sales	4.12
EV / EBITDA	13.08
EV / EBIT	17.03
EV / FCF	18.21

Financial Position

The company has a current ratio of 3.75, with a Debt / Equity ratio of 0.50.

Current Ratio	3.75
Quick Ratio	2.87
Debt / Equity	0.50
Debt / EBITDA	1.94
Debt / FCF	2.73
Interest Coverage	8.47

Financial Efficiency

Return on equity (ROE) is 11.12% and return on invested capital (ROIC) is 8.08%.

Return on Equity (ROE)	11.12%
Return on Assets (ROA)	6.82%
Return on Invested Capital (ROIC)	8.08%
Return on Capital Employed (ROCE)	12.34%
Revenue Per Employee	3.10M
Profits Per Employee	427,875
Employee Count	7,063
Asset Turnover	0.45
Inventory Turnover	2.35

Taxes

In the past 12 months, Hologic has paid 617.02 million in taxes.

Income Tax	617.02M
Effective Tax Rate	16.96%

Stock Price Statistics

The stock price has decreased by -10.52% in the last 52 weeks. The beta is 0.71, so Hologic's price volatility has been lower than the market average.

Beta (5Y)	0.71
52-Week Price Change	-10.52%
50-Day Moving Average	378.08
200-Day Moving Average	n/a
Relative Strength Index (RSI)	53.93
Average Volume (20 Days)	123

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	1.18

Income Statement

In the last 12 months, Hologic had revenue of BRL 21.91 billion and earned 3.02 billion in profits. Earnings per share was 13.30.

Revenue	21.91B
Gross Profit	13.36B
Operating Income	5.30B
Pretax Income	3.64B
Net Income	3.02B
EBITDA	6.90B
EBIT	5.30B
Earnings Per Share (EPS)	13.30

Balance Sheet

The company has 11.77 billion in cash and 13.40 billion in debt, giving a net cash position of -1.63 billion.

Cash & Cash Equivalents	11.77B
Total Debt	13.40B
Net Cash	-1.63B
Net Cash Per Share	n/a
Equity (Book Value)	26.97B
Book Value Per Share	120.25
Working Capital	14.38B

Cash Flow

In the last 12 months, operating cash flow was 5.65 billion and capital expenditures -731.88 million, giving a free cash flow of 4.92 billion.

Operating Cash Flow	5.65B
Capital Expenditures	-731.88M
Free Cash Flow	4.92B
FCF Per Share	n/a

Margins

Gross margin is 61.00%, with operating and profit margins of 24.19% and 13.80%.

Gross Margin	61.00%
Operating Margin	24.19%
Pretax Margin	16.61%
Profit Margin	13.80%
EBITDA Margin	31.51%
EBIT Margin	24.19%
FCF Margin	22.44%

Dividends & Yields

Hologic does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	4.20%
Shareholder Yield	4.20%
Earnings Yield	3.44%
FCF Yield	5.59%

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value
Lynch Upside
Graham Number
Graham Upside

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

Altman Z-Score	n/a
Piotroski F-Score	7